跳至主要内容
临床试验/EUCTR2019-001914-41-SI
EUCTR2019-001914-41-SI进行中(未招募)1 期

Prospective randomised trial of first line treatments of Helicobacter pylori infection in Slovenia

Slovensko Združenje za gastroenterologijo in hepatologijo0 个研究点目标入组 280 人开始时间: 2019年10月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients 18 to 80 years old.
  • Patients have not received proton pump inhibitors for the past 14 days.
  • Patients did not receive antibiotics last month.
  • Helicobacter pylori infection was demonstrated with a rapid urease test.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 280
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 90

排除标准

  • Pre-treatment of Helicobacter pylori infection.
  • Defects in blood clotting, for example taking anticoagulant medicines that make it impossible to take biopsies.
  • Drug allergy used in the study.
  • Pregnancy, breastfeeding.
  • Psychiatric illness that would make it impossible to participate in the research.
  • Active treatment for malignancy.

研究者

发起方
Slovensko Združenje za gastroenterologijo in hepatologijo

相似试验